The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer: A Meta-analysis
Abstract
CONTEXT: Despite potentially curative resection of stomach cancer, 50% to 90% of patients die of disease relapse. Numerous randomized clinical trials (RCTs) have compared surgery alone with adjuvant chemotherapy, but definitive evidence is lacking. OBJECTIVES: To perform an individual patient-level meta-analysis of all RCTs to quantify the potential benefit of chemotherapy after complete resection over surgery alone in terms of overall survival and disease-free survival, and to further study the role of regimens, including monochemotherapy; combined chemotherapy with fluorouracil derivatives, mitomycin C, and other therapies but no anthracyclines; combined chemotherapy with fluorouracil derivatives, mitomycin C, and anthracyclines; and other treatments. DATA SOURCES: Data from all RCTs comparing adjuvant chemotherapy with surgery alone in patients with resectable gastric cancer. We searched MEDLINE (up to 2009), the Cochrane Central Register of Controlled Trials, the National Institutes of Health trial registry, and published proceedings from major oncologic and gastrointestinal cancer meetings. STUDY SELECTION: All RCTs closed to patient recruitment before 2004 were eligible. Trials testing radiotherapy; neoadjuvant, perioperative, or intraperitoneal chemotherapy; or immunotherapy were excluded. Thirty-one eligible trials (6390 patients) were identified. DATA EXTRACTION: As of 2010, individual patient data were available from 17 trials (3838 patients representing 60% of the targeted data) with a median follow-up exceeding 7 years. RESULTS: There were 1000 deaths among 1924 patients assigned to chemotherapy groups and 1067 deaths among 1857 patients assigned to surgery-only groups. Adjuvant chemotherapy was associated with a statistically significant benefit in terms of overall survival (hazard ratio [HR], 0.82; 95% confidence interval [CI], 0.76-0.90; P < .001) and disease-free survival (HR, 0.82; 95% CI, 0.75-0.90; P < .001). There was no significant heterogeneity for overall survival across RCTs (P = .52) or the 4 regimen groups (P = .13). Five-year overall survival increased from 49.6% to 55.3% with chemotherapy. CONCLUSION: Among the RCTs included, postoperative adjuvant chemotherapy based on fluorouracil regimens was associated with reduced risk of death in gastric cancer compared with surgery alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Macdonald, J. S., Smalley, S. R., Benedetti, J., Hundahl, S. A., Estes, N. C., Stemmermann, G. N., Haller, D. G., Ajani, J. A., Gunderson, L. L., Jessup, J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010187 · Cited by 3,475
A note on quantifying follow-up in studies of failure time
Schemper, M., & Smith, T. L. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(96)00075-x · Cited by 2,575
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Sakuramoto, S., Sasako, M., Yamaguchi, T., Kinoshita, T., Fujii, M., Nashimoto, A., Furukawa, H., Nakajima, T., Ohashi, Y., Imamura, H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072252 · Cited by 2,517
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
Epidemiology of gastric cancer
Crew, K. D., & Neugut, A. I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.354 · Cited by 2,108
Gebski, V., Burmeister, B., Smithers, B. M., Foo, K., Zalcberg, J., & Simes, J. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70039-6 · Cited by 1,158
Early Breast Cancer Trialists’ Collaborative Group, & Peto, R. (1993) · Recent Results in Cancer Research · doi:10.1007/978-3-642-84745-5_21 · Cited by 958
Ajani, J. A., Rodriguez, W., Bodoky, G., Moiseyenko, V., Lichinitser, M., Gorbunova, V., Vynnychenko, I., Garin, A., Lang, I., & Falcon, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4706 · Cited by 550
Practical methodology of meta‐analyses (overviews) using updated individual patient data
Stewart, L. A., & Cochrane Working Group On Meta‐Analysis Using Individual Patient Data (1995) · Statistics in Medicine · doi:10.1002/sim.4780141902 · Cited by 492
Chemotherapy in gastric cancer: a review and updated meta-analysis
Janunger, K.-G., Hafström, L., & Glimelius, B. (2002) · The European Journal of Surgery · doi:10.1080/11024150201680005 · Cited by 224
Nakajima, T., Nashimoto, A., Kitamura, M., Kito, T., Iwanaga, T., Okabayashi, K., Sasaki, M., & Goto, M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01048-x · Cited by 166
Nashimoto, A., Nakajima, T., Furukawa, H., Kitamura, M., Kinoshita, T., Yamamura, Y., Sasako, M., Kunii, Y., Motohashi, H., Yamamoto, S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.103 · Cited by 164
Coombes, R. C., Schein, P. S., Chilvers, C. E. D., Wils, J. A., Beretta, G. D., Bliss, J. M., Rutten, A., Amadori, D., Cortés-Funes, H., & Grimalt, A. V. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.8.1362 · Cited by 154
Bouché, O., Ychou, M., Burtin, P. C., Bedenne, L., Ducreux, M. P., Lebreton, G., Baulieux, J., Nordlinger, B., Martin, C., Seitz, J., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi270 · Cited by 150
Engstrom, P. F., Lavin, P. T., Douglass, H. O., & Brunner, K. W. (1985) · Cancer · doi:10.1002/1097-0142(19850501)55:9<1868::aid-cncr2820550904>3.0.co;2-b · Cited by 141
Bajetta, E., Buzzoni, R., Mariani, L., Beretta, E., Bozzetti, F., Bordogna, G., Aitini, E., Fava, S., Schieppati, G., Pinotti, G., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf040 · Cited by 138
Nakajima, T., Kinoshitá, T., Nashimoto, A., Sairenji, M., Yamaguchi, T., Sakamoto, J., Fujiya, T., Inada, T., Sasako, M., & Ohashi, Y. (2007) · British journal of surgery · doi:10.1002/bjs.5996 · Cited by 134
Costanzo, F. D., Gasperoni, S., Manzione, L., Bisagni, G., Labianca, R., Bravi, S., Cortesi, E., Carlini, P., Bracci, R., Tomao, F., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn054 · Cited by 127
Macdonald, J. S., Fleming, T. R., Peterson, R. F., Berenberg, J. L., McClure, S., Chapman, R., Eyre, H. J., Solanki, D. L., Cruz, A. B., Gagliano, R. G., et al. (1995) · Annals of Surgical Oncology · doi:10.1007/bf02307081 · Cited by 123
Cirera, L., Balil, A., Batiste-Alentorn, E., Tusquets, I., Cardona, T., Arcusa, À., Jolis, L., Saigí, E., Guasch, I., Badia, A. C., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3810 · Cited by 115
Lise, M., Nitti, D., Marchet, A., Sahmoud, T., Buyse, M. E., Duez, N. J., Fiorentino, M. V., Santos, J. G. D., Labianca, R., & Rougier, P. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2757 · Cited by 108
Vita, F. D., Giuliani, F., Orditura, M., Maiello, E., Galizia, G., Martino, N. D., Montemurro, F., Cartenì, G., Manzione, L., Romito, S., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm128 · Cited by 103
ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCER
Allum, W. H., Hallissey, M. T., Kelly, K., & British Stomach Cancer Group (1989) · The Lancet · doi:10.1016/s0140-6736(89)91607-3 · Cited by 99
Meta-analyses of randomised clinical trials in oncology
Pignon, J., & Hill, C. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00453-3 · Cited by 94
Nitti, D., Wils, J., dos Santos, J. G., Fountzilas, G., Conte, P., Sava, C., Tres, A., Coombes, R. C., Crivellari, D., Marchet, A., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj077 · Cited by 92
An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer
Liu, T. S., Wang, Y., Chen, S. Y., & Sun, Y. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.02.002 · Cited by 82
Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer
Chipponi, J., Huguier, M., Pezet, D., Basso, N., Hay, J., Quandalle, P. A., Jaeck, D., Fagniez, P., & Gainant, A. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.12.014 · Cited by 62
Popiela, T. J., Kulig, J., Czupryna, A., Szczepanik, A., & Zembala, M. (2004) · Gastric Cancer · doi:10.1007/s10120-004-0299-y · Cited by 40
Cited by
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31288-5 · Cited by 4,803
Ychou, M., Boige, V., Pignon, J.-P., Conroy, T., Bouché, O., Lebreton, G., Ducourtieux, M., Bedenne, L., Fabre, J.-M., Saint-Aubert, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0597 · Cited by 2,086
Van Cutsem, E., Sagaert, X., Topal, B., Haustermans, K., & Prenen, H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30354-3 · Cited by 1,793
Bang, Y.-J., Kim, Y.-W., Yang, H.-K., Chung, H. C., Park, Y.-K., Lee, K. H., Lee, K.-W., Kim, Y. H., Noh, S.-I., Cho, J. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61873-4 · Cited by 1,705
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Smyth, E. C., Verheij, M., Allum, W., Cunningham, D., Cervantes, A., & Arnold, D. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw350 · Cited by 1,555
Metadata
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-05-05
- Volume
- 303
- Issue
- 17
- Pages
- 1729
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W12636511
- Cited by
- 794
- References
- 33
- FWCI
- 51.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.